Evidence mapPaperPMID 35018308Full record

ArticleClinical epidemiology and global health

Health-related quality of life among COVID-19 individuals: A cross-sectional study in Tamil Nadu, India.

Suganya Barani, Tarun Bhatnagar, Meenakumari Natarajan, Kumari Gayathri, Harshal Bhimrao Sonekar, Akhil Sasidharan, T S Selvavinayagam, Bhavani Shankara Bagepally

Abstract read
In one paragraph

Article in Clinical epidemiology and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Acute SARS-CoV-2 infection.Nature reviews. Disease primers · 2025
    Review
  4. Article
  5. Article
  6. Post-COVID-19 Condition and Pulmonary Embolism.Journal of multidisciplinary healthcare · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Health-Related Quality of Life Among Patients Recovered From COVID-19.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suganya BaraniDirectorate of Public Health and Preventive Medicine, Tamil Nadu, India.
Tarun BhatnagarICMR-National Institute of Epidemiology, Chennai, India.
Meenakumari NatarajanICMR-National Institute of Epidemiology, Chennai, India.
Kumari GayathriICMR-National Institute of Epidemiology, Chennai, India.
Harshal Bhimrao SonekarICMR-National Institute of Epidemiology, Chennai, India.
Akhil SasidharanICMR-National Institute of Epidemiology, Chennai, India.
T S SelvavinayagamDirectorate of Public Health and Preventive Medicine, Tamil Nadu, India.
Bhavani Shankara BagepallyICMR-National Institute of Epidemiology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe EQ-5D-5L questionnaire is a tool that is a very generic and preference-based instrument to describe the health-related quality of life. We have generated the stratified index utility value for the Tamil Nadu population and compared the utility values based on socio-demographic and clinical characteristics.

methodsWe conducted a community-based analytical cross-sectional study using telephonic interviews from November 2020 till December 2020 among individuals aged 18 years and above who were infected by the coronavirus confirmed with an RT-PCR within 30 days in Tamil Nadu State. EQ-5D-5L profile, socio-demographic and clinical characteristics of the study participants were collected and analysed.

resultsWe interviewed 372 participants, with 57.5% were males, and their mean age was 44.5 ± 15.3 years. About 40% of participants reported as having comorbidities, such as diabetes (19.4%), hypertension (12.4%), heart disease (2.4%), kidney disease (0.8%) and others. The mean EQ-5D utility score was 0.925 ± 0.150, and the mean EQ-VAS was 90.68 ± 11.81. Overall, men had a higher utility value (0.938 ± 0.130) than women, (0.907 ± 0.170). Individuals with comorbidities, requiring longer hospitalisation were having lower utility scores than their counterparts.

conclusionWe report the EQ-5D-5L utility values for the COVID-19 illness. These values would help to estimate quality-adjusted life years in health economic evaluation studies.

Indexed as

COVID-19Cross-sectionalHRQOLQuality of life

Identifiers

PMID35018308
PMCPMC8739503

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.